These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21067398)

  • 21. Myocardial collagen turnover in hypertrophic cardiomyopathy.
    Lombardi R; Betocchi S; Losi MA; Tocchetti CG; Aversa M; Miranda M; D'Alessandro G; Cacace A; Ciampi Q; Chiariello M
    Circulation; 2003 Sep; 108(12):1455-60. PubMed ID: 12952838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relationship between myocardial modelling and diastolic function in patients with essential hypertension].
    Cortés R; Roselló-Lletí E; Portolés M; Almenar L; Martínez-Dolz L; Grigorian L; García de Burgos F; Carpena N; Salvador A; Bertomeu V; Rivera M
    Med Clin (Barc); 2012 Oct; 139(8):325-30. PubMed ID: 22036455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Genetic aspects of myocardial hypertrophy in hypertrophic cardiomyopathy and arterial hypertension].
    Smirnova MD; Fofanova TV; Postnov AIu; Ageev FT
    Ter Arkh; 2008; 80(1):77-84. PubMed ID: 18326235
    [No Abstract]   [Full Text] [Related]  

  • 24. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
    Arad M; Maron BJ; Gorham JM; Johnson WH; Saul JP; Perez-Atayde AR; Spirito P; Wright GB; Kanter RJ; Seidman CE; Seidman JG
    N Engl J Med; 2005 Jan; 352(4):362-72. PubMed ID: 15673802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Early diastolic dysfunction of the left ventricle affected by hypertrophy and abnormal histopathology in hypertrophic cardiomyopathy].
    Sugihara N; Shimizu M; Suematsu T; Horita Y; Shimizu K; Ohsato K; Shibayama S; Nakao T; Kitamura M; Takeda R
    J Cardiol; 1990; 20(1):71-81. PubMed ID: 2151236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resolution of left ventricular and asymmetric septal hypertrophy after resection of left ventricular outflow obstruction in a patient with troponin-positive hypertrophic obstructive cardiomyopathy: a case report.
    Narsupalli S; Castle B; Veldtman G
    Cardiol Young; 2010 Oct; 20(5):580-3. PubMed ID: 20663266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Matrix Metalloproteinases as Quantitative Biomarkers for Myocardial Fibrosis and Sudden Cardiac Death Risk Stratification in Patients With Hypertrophic Cardiomyopathy.
    Münch J; Avanesov M; Bannas P; Säring D; Krämer E; Mearini G; Carrier L; Suling A; Lund G; Patten M
    J Card Fail; 2016 Oct; 22(10):845-50. PubMed ID: 27018569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum Biomarkers of Myocardial Remodeling and Coronary Dysfunction in Early Stages of Hypertrophic Cardiomyopathy in the Young.
    Fernlund E; Gyllenhammar T; Jablonowski R; Carlsson M; Larsson A; Ärnlöv J; Liuba P
    Pediatr Cardiol; 2017 Apr; 38(4):853-863. PubMed ID: 28361263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis.
    Querejeta R; López B; González A; Sánchez E; Larman M; Martínez Ubago JL; Díez J
    Circulation; 2004 Sep; 110(10):1263-8. PubMed ID: 15313958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left ventricular hypertrophy in Fabry disease: a practical approach to diagnosis.
    Yousef Z; Elliott PM; Cecchi F; Escoubet B; Linhart A; Monserrat L; Namdar M; Weidemann F
    Eur Heart J; 2013 Mar; 34(11):802-8. PubMed ID: 22736678
    [No Abstract]   [Full Text] [Related]  

  • 31. A biomarker of myocardial fibrosis predicts long-term response to cardiac resynchronization therapy.
    García-Bolao I; Macías A; López B; González A; Gavira JJ; Azcárate P; Alegría E; Díez J
    J Am Coll Cardiol; 2006 Jun; 47(11):2335-7. PubMed ID: 16750706
    [No Abstract]   [Full Text] [Related]  

  • 32. Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy.
    Christiaans I; Lekanne dit Deprez RH; van Langen IM; Wilde AA
    Heart Rhythm; 2009 Sep; 6(9):1366-9. PubMed ID: 19539541
    [No Abstract]   [Full Text] [Related]  

  • 33. Features of cardiac remodeling, associated with blood pressure and fibrosis biomarkers, are frequent in subjects with abdominal obesity.
    Eschalier R; Rossignol P; Kearney-Schwartz A; Adamopoulos C; Karatzidou K; Fay R; Mandry D; Marie PY; Zannad F
    Hypertension; 2014 Apr; 63(4):740-6. PubMed ID: 24446063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
    Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
    Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated backscatter as a fibrosis marker in the metabolic syndrome: association with biochemical evidence of fibrosis and left ventricular dysfunction.
    Kosmala W; Przewlocka-Kosmala M; Wojnalowicz A; Mysiak A; Marwick TH
    Eur Heart J Cardiovasc Imaging; 2012 Jun; 13(6):459-67. PubMed ID: 22185752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertrophic cardiomyopathy: case report.
    Mukhtar AU; Ihunwo AO
    East Afr Med J; 1999 Sep; 76(9):535-6. PubMed ID: 10685328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biochemical diagnosis of left ventricular remodelling in refractory hypertension].
    Díez J
    Med Clin (Barc); 2012 Feb; 138(4):155-6. PubMed ID: 21939997
    [No Abstract]   [Full Text] [Related]  

  • 39. Prognostic value of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Fatkin D; Graham RM
    N Engl J Med; 2001 Jan; 344(1):63-5. PubMed ID: 11187116
    [No Abstract]   [Full Text] [Related]  

  • 40. [Platelet aggregation in patients with hypertrophic cardiomyopathy].
    Riazanov AS; Gabbasov ZA; Iurenev AP
    Ter Arkh; 2000; 72(8):36-8. PubMed ID: 11019425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.